Clinical Trial Detail

NCT ID NCT02711345
Title A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

melanoma

Therapies

LTT462

Age Groups: adult senior

No variant requirements are available.